CA2126356A1 - Serum-albumine humaine, preparation et utilisation - Google Patents
Serum-albumine humaine, preparation et utilisationInfo
- Publication number
- CA2126356A1 CA2126356A1 CA002126356A CA2126356A CA2126356A1 CA 2126356 A1 CA2126356 A1 CA 2126356A1 CA 002126356 A CA002126356 A CA 002126356A CA 2126356 A CA2126356 A CA 2126356A CA 2126356 A1 CA2126356 A1 CA 2126356A1
- Authority
- CA
- Canada
- Prior art keywords
- pct
- preparation
- albumin
- human serum
- sec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000008100 Human Serum Albumin Human genes 0.000 title 1
- 108091006905 Human Serum Albumin Proteins 0.000 title 1
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 108091029865 Exogenous DNA Proteins 0.000 abstract 1
- 238000004737 colorimetric analysis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
2126356 9315204 PCTABS00163 La présente invention concerne une préparation de sérum-albumine humaine ayant un indice de colorimétrie inférieur à 0,2, résultant de l'expression, dans un hôte eucaryote ou procaryote, d'une séquence d'ADN exogène.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR92/00807 | 1992-01-27 | ||
FR9200807A FR2686620B1 (fr) | 1992-01-27 | 1992-01-27 | Serum-albumine humaine, preparation et utilisation. |
PCT/FR1993/000072 WO1993015204A1 (fr) | 1992-01-27 | 1993-01-26 | Serum-albumine humaine, preparation et utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2126356A1 true CA2126356A1 (fr) | 1993-08-05 |
CA2126356C CA2126356C (fr) | 2003-03-18 |
Family
ID=9425981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002126356A Expired - Fee Related CA2126356C (fr) | 1992-01-27 | 1993-01-26 | Serum-albumine humaine, preparation et utilisation |
Country Status (16)
Country | Link |
---|---|
US (1) | US5612196A (fr) |
EP (1) | EP0625202B1 (fr) |
JP (1) | JP3390990B2 (fr) |
AT (1) | ATE182623T1 (fr) |
AU (1) | AU686996B2 (fr) |
CA (1) | CA2126356C (fr) |
DE (1) | DE69325794T2 (fr) |
DK (1) | DK0625202T3 (fr) |
ES (1) | ES2137251T3 (fr) |
FI (1) | FI943512A (fr) |
FR (1) | FR2686620B1 (fr) |
GR (1) | GR3030873T3 (fr) |
HU (1) | HU218353B (fr) |
NO (1) | NO310418B1 (fr) |
NZ (1) | NZ249153A (fr) |
WO (1) | WO1993015204A1 (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US5728553A (en) * | 1992-09-23 | 1998-03-17 | Delta Biotechnology Limited | High purity albumin and method of producing |
CA2136564C (fr) * | 1993-11-26 | 2008-04-08 | Kaoru Kobayashi | Mode de fabrication d'albumine serique humaine |
GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
GB9902000D0 (en) * | 1999-01-30 | 1999-03-17 | Delta Biotechnology Ltd | Process |
EP1276849A4 (fr) * | 2000-04-12 | 2004-06-09 | Human Genome Sciences Inc | Proteines fusionnees a de l'albumine |
US6946134B1 (en) | 2000-04-12 | 2005-09-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US6762053B2 (en) * | 2000-06-09 | 2004-07-13 | Vitrolife, Inc. | Mammalian gamete and embryo culture media and culture media supplements |
US20060084794A1 (en) * | 2001-04-12 | 2006-04-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20050054051A1 (en) * | 2001-04-12 | 2005-03-10 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20050244931A1 (en) * | 2001-04-12 | 2005-11-03 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7507413B2 (en) | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
WO2003030821A2 (fr) * | 2001-10-05 | 2003-04-17 | Human Genome Sciences, Inc. | Proteines de fusion d'albumine |
EP1463752A4 (fr) * | 2001-12-21 | 2005-07-13 | Human Genome Sciences Inc | Proteines de fusion d'albumine |
EP2277889B1 (fr) * | 2001-12-21 | 2014-07-09 | Human Genome Sciences, Inc. | Protéines chimériques d'albumine et interféron beta |
CA2513213C (fr) | 2003-01-22 | 2013-07-30 | Human Genome Sciences, Inc. | Proteines hybrides d'albumine |
BRPI0507026A (pt) * | 2004-02-09 | 2007-04-17 | Human Genome Sciences Inc | proteìnas de fusão de albumina |
WO2006066595A2 (fr) * | 2004-12-22 | 2006-06-29 | Novozymes A/S | Production par recombinaison de serum-albumine |
WO2010059315A1 (fr) | 2008-11-18 | 2010-05-27 | Merrimack Pharmaceuticals, Inc. | Lieurs de sérum-albumine humaine et conjugués de ceux-ci |
CN102127164B (zh) | 2010-12-20 | 2013-01-30 | 武汉禾元生物科技有限公司 | 一种从水稻种子中提取重组人血清白蛋白的方法 |
CN102532254B (zh) | 2010-12-24 | 2015-06-24 | 武汉禾元生物科技股份有限公司 | 一种从水稻种子中分离纯化重组人血清白蛋白的方法 |
BR112014000042A2 (pt) | 2011-07-05 | 2017-02-21 | Novozymes Biopharma Dk As | composição, meio de cultura celular, uso de uma composição, e, método para cultivar células |
US9345766B2 (en) | 2012-08-30 | 2016-05-24 | Merrimack Pharmaceuticals, Inc. | Combination therapies comprising anti-ERBB3 agents |
CN103880947B (zh) | 2012-12-21 | 2016-01-13 | 武汉禾元生物科技股份有限公司 | 一种分离纯化高纯度重组人血清白蛋白的层析方法 |
ES2780367T3 (es) * | 2015-01-01 | 2020-08-25 | Shilpa Medicare Ltd | Nuevo método de purificación eficiente de albumina sérica humana |
US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
WO2024018452A1 (fr) | 2022-07-18 | 2024-01-25 | Yeda Research And Development Co. Ltd. | Variants de protéine d'albumine, leur production et leurs utilisations |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE405549B (sv) * | 1975-10-09 | 1978-12-18 | Pharmacia Fine Chemicals Ab | Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering |
NL7708005A (nl) * | 1976-07-22 | 1978-01-24 | Monsanto Co | Werkwijze voor de bereiding van serumalbumine. |
JPS62294621A (ja) * | 1986-06-13 | 1987-12-22 | Green Cross Corp:The | アルブミンの回収方法 |
IL89992A0 (en) * | 1988-04-25 | 1989-12-15 | Phillips Petroleum Co | Expression of human serum albumin in methylotrophic yeasts |
FR2635115B1 (fr) * | 1988-08-05 | 1992-04-03 | Rhone Poulenc Sante | Procede de preparation de la serum albumine humaine a partir d'une levure |
FR2649991B2 (fr) * | 1988-08-05 | 1994-03-04 | Rhone Poulenc Sante | Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces |
GB8923521D0 (en) * | 1989-10-18 | 1989-12-06 | Delta Biotechnology Ltd | Yeast promoter |
JP3230091B2 (ja) * | 1990-06-25 | 2001-11-19 | ウェルファイド株式会社 | ヒト血清アルブミンの着色抑制方法 |
US5330901A (en) * | 1991-04-26 | 1994-07-19 | Research Corporation Technologies, Inc. | Expression of human serum albumin in Pichia pastoris |
FR2677996B1 (fr) * | 1991-06-21 | 1993-08-27 | Rhone Poulenc Rorer Sa | Vecteurs de clonage et/ou d'expression preparation et utilisation. |
-
1992
- 1992-01-27 FR FR9200807A patent/FR2686620B1/fr not_active Expired - Fee Related
-
1993
- 1993-01-26 CA CA002126356A patent/CA2126356C/fr not_active Expired - Fee Related
- 1993-01-26 HU HU9401960A patent/HU218353B/hu not_active IP Right Cessation
- 1993-01-26 NZ NZ249153A patent/NZ249153A/en not_active IP Right Cessation
- 1993-01-26 DE DE69325794T patent/DE69325794T2/de not_active Expired - Lifetime
- 1993-01-26 WO PCT/FR1993/000072 patent/WO1993015204A1/fr active IP Right Grant
- 1993-01-26 JP JP51298093A patent/JP3390990B2/ja not_active Expired - Fee Related
- 1993-01-26 US US08/256,966 patent/US5612196A/en not_active Expired - Lifetime
- 1993-01-26 AU AU35038/93A patent/AU686996B2/en not_active Ceased
- 1993-01-26 AT AT93904116T patent/ATE182623T1/de not_active IP Right Cessation
- 1993-01-26 DK DK93904116T patent/DK0625202T3/da active
- 1993-01-26 ES ES93904116T patent/ES2137251T3/es not_active Expired - Lifetime
- 1993-01-26 EP EP93904116A patent/EP0625202B1/fr not_active Revoked
-
1994
- 1994-07-26 FI FI943512A patent/FI943512A/fi not_active Application Discontinuation
- 1994-07-26 NO NO19942780A patent/NO310418B1/no not_active IP Right Cessation
-
1999
- 1999-07-29 GR GR990401634T patent/GR3030873T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HU218353B (hu) | 2000-08-28 |
US5612196A (en) | 1997-03-18 |
JPH07503137A (ja) | 1995-04-06 |
DK0625202T3 (da) | 2000-02-28 |
EP0625202B1 (fr) | 1999-07-28 |
NO942780D0 (no) | 1994-07-26 |
JP3390990B2 (ja) | 2003-03-31 |
ATE182623T1 (de) | 1999-08-15 |
NZ249153A (en) | 1996-03-26 |
AU3503893A (en) | 1993-09-01 |
GR3030873T3 (en) | 1999-11-30 |
WO1993015204A1 (fr) | 1993-08-05 |
FI943512A0 (fi) | 1994-07-26 |
FI943512A (fi) | 1994-07-26 |
HUT70570A (en) | 1995-10-30 |
HU9401960D0 (en) | 1994-09-28 |
EP0625202A1 (fr) | 1994-11-23 |
AU686996B2 (en) | 1998-02-19 |
ES2137251T3 (es) | 1999-12-16 |
DE69325794D1 (de) | 1999-09-02 |
NO942780L (no) | 1994-07-26 |
FR2686620A1 (fr) | 1993-07-30 |
CA2126356C (fr) | 2003-03-18 |
DE69325794T2 (de) | 2000-01-13 |
FR2686620B1 (fr) | 1995-06-23 |
NO310418B1 (no) | 2001-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2126356A1 (fr) | Serum-albumine humaine, preparation et utilisation | |
CA2075060A1 (fr) | Essences pour vehicules et leur utilisation dans des preparations medicales | |
AU5833994A (en) | Pharmaceutical and dermocosmetic compositions containing equine colostrum | |
CA2222914A1 (fr) | Nouvelle muteine de cd40l | |
AU2885295A (en) | Novel hIL-4 mutant proteins as antagonists or partial agonists of human interleukin 4 | |
GB2302329B (en) | Yeast strains | |
AU3078892A (en) | Human interleukin-8 analogs | |
AU2928292A (en) | Human il-4 mutant proteins | |
AU1725797A (en) | Parapoxviruses which contain foreign DNA, their preparation and their use in vaccines | |
GR3024667T3 (en) | Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use. | |
AU8332791A (en) | Oral pharmaceutical compositions containing melatonin | |
DE69302375D1 (de) | Kosmetische zusammensetzung zur erhaltung der frisur enthaltend ein milchprotein und/oder ein milchproteinhydrolysate und ein hydrolysate | |
ZA932164B (en) | Moisturizer. | |
ES2071343T3 (es) | Nuevos peptidos con actividad anticoagulatoria. | |
ZA932748B (en) | Water-soluble retinoids | |
DE69425061D1 (de) | Verwendung von einer suspension auf der basis von sucralfatgel als antazidum | |
ZA953584B (en) | Novel active peptide and its preparation | |
CA2115992A1 (fr) | Utilisation d'esters aminoalcanolamide comme adjuvants de traitement pour les thermoplastiques | |
WO2000027881A3 (fr) | Proteines mutees de l'interleukine 10 humaine | |
ZA939227B (en) | Novel triazoloquinazolines,their preparation and use | |
NZ330913A (en) | Antigens for preventing and reducing parasite infection and disease | |
Tipton et al. | Letter to Readers, Table of Contents, and Members of the National Seminar on Jesuit Higher Education |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |